TrialBlood2018

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.

Eytan M Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.